Related Experiment Video
Updated: May 23, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
Published on: June 8, 2022
Predictors of survival in Chinese patients with lupus nephritis
Z H Zheng1, L J Zhang, W X Liu
1Department of Nephrology and Rheumatology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Insights
Predictors of survival in lupus nephritis (LN) were identified. Renal dysfunction and massive proteinuria are key risk factors, while hydroxychloroquine (HCQ) significantly improves survival rates in LN patients.
Area of Science:
- Nephrology
- Immunology
- Clinical Medicine
Background:
- Lupus nephritis (LN) is a severe complication of systemic lupus erythematosus.
- Understanding survival predictors is crucial for managing LN patients.
Purpose of the Study:
- To identify predictors of survival in a cohort of Chinese patients with lupus nephritis.
- To evaluate the impact of specific clinical factors and treatments on long-term outcomes.
Main Methods:
- Retrospective analysis of 491 Chinese patients with lupus nephritis followed from 2003 to 2010.
- Kaplan-Meier survival analysis, log-rank tests, and multivariate Cox regression modeling were employed.
Main Results:
- Overall 5, 10, 15, and 20-year survival probabilities were 88%, 77%, 53%, and 45%, respectively.
- Increased creatinine, massive proteinuria, and late-onset disease were associated with decreased survival.
- Treatment with hydroxychloroquine (HCQ) and glucocorticoids was linked to improved survival.
Conclusions:
- Elevated creatinine and massive proteinuria are independent risk factors for mortality in lupus nephritis.
- Hydroxychloroquine (HCQ) demonstrates a significant protective effect, improving survival in LN patients.
Abstract:
The current study was to determine the predictors of survival in 491 Chinese patients with lupus nephritis (LN). All patients were evaluated and consecutively followed up from 2003 to 2010. The female: male ratio was 9.5:1, with a median age of 31.1 ± 12 years. Forty-nine (10.0%) patients were lost to follow-up and 47 (10.3%) patients died. The overall cumulative probability of survival at 5, 10, 15 and 20 years by Kaplan-Meier analysis was 88%, 77%, 53% and 45%, respectively. The log-rank test showed that the probability of survival was significantly decreased in the late-onset patients (≥50 years) (P = 0.036), patients with hypoproteinaemia (≤35 g/l) (P = 0.014), patients with increased creatinine (≥1.5 mg/dl) (P = 0.002) and patients with massive proteinuria (≥3.5 g/24 h) (P = 0.009). However, the probability of survival was significantly higher in patients treated with hydroxychloroquine (HCQ) (P = 0.003) than those not treated with it. Based on a multivariate model, increased creatinine (hazard ratio (HR) = 2.041; P = 0.017) and proteinuria ≥3.5 g/24hours (HR=1.716; P = 0.016) were independent risk factors. Glucocorticoid (HR = 0.457; P = 0.01) and HCQ (HR=0.197; P = 0.026) were independent protective factors. Our findings suggest that renal dysfunction and massive proteinuria are independent risk factors for mortality. HCQ could improve the survival of patients with LN.
Related Concept Videos
Cancer Survival Analysis
Nephrotic Syndrome III : Nursing Management